{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,15]],"date-time":"2026-10-15T00:45:50Z","timestamp":1792025150326,"version":"4.4.0"},"reference-count":32,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2020,10,30]],"date-time":"2020-10-30T00:00:00Z","timestamp":1604016000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2020,10,30]],"date-time":"2020-10-30T00:00:00Z","timestamp":1604016000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"Medizinische Hochschule Hannover (MHH)"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Neural Transm"],"published-print":{"date-parts":[[2021,4]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Botulinum toxin (BT) is used to treat a large number of muscle hyperactivity syndromes. Its use in dystonia, however, is still one of the most important indications for BT therapy. When BT is injected into dystonic muscles, it produces a peripheral paresis which is localised, well controllable and follows a distinct and predictable time course of around 3\u00a0months. Adverse effects are always transient and usually mild, long-term application is safe. With this profile BT can be used to treat cranial dystonia, cervical dystonia and limb dystonia including writer\u2019s and musician's cramps. The recent introduction of BT high dose therapy also allows to treat more wide-spread dystonia including segmental and generalised dystonia. BT can easily be combined with other anti-dystonic treatments such as deep brain stimulation and intrathecal baclofen application. Best treatment results are obtained when BT therapy is integrated in the multimodal and long-term 'multilayer concept of treatment of dystonia'. The biggest challenge for the future will be to deliver state of the art BT therapy to all dystonia patients in need, regardless of whether they live in developed countries or beyond.<\/jats:p>","DOI":"10.1007\/s00702-020-02266-z","type":"journal-article","created":{"date-parts":[[2020,10,30]],"date-time":"2020-10-30T15:02:41Z","timestamp":1604070161000},"page":"531-537","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":64,"title":["Botulinum toxin therapy of dystonia"],"prefix":"10.1007","volume":"128","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-3612-3796","authenticated-orcid":false,"given":"Dirk","family":"Dressler","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fereshte","family":"Adib Saberi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Raymond L.","family":"Rosales","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2020,10,30]]},"reference":[{"key":"2266_CR1","doi-asserted-by":"publisher","first-page":"705","DOI":"10.1007\/s00702-012-0932-6","volume":"120","author":"F Adib Saberi","year":"2013","unstructured":"Adib Saberi F, Dressler D (2013) Interdisziplin\u00e4rer Arbeitskreis Bewegungsst\u00f6rungen (IAB): a new approach for promoting interdisciplinary therapy of movement disorders. J Neural Transm 120:705\u2013710","journal-title":"J Neural Transm"},{"key":"2266_CR2","doi-asserted-by":"publisher","first-page":"e14","DOI":"10.1111\/j.1468-1331.2007.01821.x","volume":"14","author":"H Alonso-Navarro","year":"2007","unstructured":"Alonso-Navarro H, Puertas I, Cabrera-Valdivia F, de Toledo-Heras M, Garc\u00eda-Albea E, Jim\u00e9nez-Jim\u00e9nez FJ (2007) Posterior auricular muscle \u201cdystonia.\u201d Eur J Neurol 14:e14-15","journal-title":"Eur J Neurol"},{"key":"2266_CR3","doi-asserted-by":"publisher","first-page":"395","DOI":"10.1002\/mds.870090404","volume":"9","author":"M Aramideh","year":"1994","unstructured":"Aramideh M, Ongerboer de Visser BW, Koelman JH, Bour LJ, Devriese PP, Speelman JD (1994) Clinical and electromyographic features of levator palpebrae superioris muscle dysfunction in involuntary eyelid closure. Mov Disord 9:395\u2013402","journal-title":"Mov Disord"},{"key":"2266_CR4","first-page":"134","volume":"45","author":"K Barth","year":"1993","unstructured":"Barth K, Dressler D (1993) Die krankengymnastische Zusammenarbeit mit Schiefhalspatienten nach der Behandlung mit Botulinum Toxin. Krankengymnastik 45:134\u2013142","journal-title":"Krankengymnastik"},{"key":"2266_CR5","doi-asserted-by":"publisher","first-page":"221","DOI":"10.1055\/s-2002-34500","volume":"33","author":"S Berweck","year":"2002","unstructured":"Berweck S, Feldkamp A, Francke A, Nehles J, Schwerin A, Heinen F (2002) Sonography-guided injection of botulinum toxin A in children with cerebral palsy. Neuropediatrics 33:221\u2013223","journal-title":"Neuropediatrics"},{"key":"2266_CR6","first-page":"CD004900","volume":"1","author":"J Costa","year":"2005","unstructured":"Costa J, Esp\u00edrito-Santo C, Borges A, Ferreira JJ, Coelho M, Moore P, Sampaio C (2005) Botulinum toxin type A therapy for blepharospasm. Cochrane Database Syst Rev 1:CD004900","journal-title":"Cochrane Database Syst Rev"},{"issue":"Suppl 1","key":"2266_CR7","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1111\/j.1468-1331.2006.01446.x","volume":"13","author":"CP Das","year":"2006","unstructured":"Das CP, Dressler D, Hallett M (2006) Botulinum toxin therapy of writer\u2019s cramp. Eur J Neurol 13(Suppl 1):55\u201359","journal-title":"Eur J Neurol"},{"key":"2266_CR8","doi-asserted-by":"publisher","first-page":"713","DOI":"10.1046\/j.1468-1331.2000.00161.x","volume":"7","author":"D Dressler","year":"2000","unstructured":"Dressler D (2000) Electromyographic evaluation of cervical dystonia for planning of botulinum toxin therapy. Eur J Neurol 7:713\u2013718","journal-title":"Eur J Neurol"},{"key":"2266_CR9","doi-asserted-by":"publisher","first-page":"385","DOI":"10.1111\/j.1468-1331.2011.03559.x","volume":"19","author":"D Dressler","year":"2012","unstructured":"Dressler D (2012) Five-year experience with incobotulinumtoxinA (Xeomin\u00ae): the first botulinum toxin drug free of complexing proteins. Eur J Neurol 19:385\u2013389","journal-title":"Eur J Neurol"},{"key":"2266_CR10","doi-asserted-by":"publisher","first-page":"437","DOI":"10.1007\/s00702-016-1628-0","volume":"124","author":"D Dressler","year":"2017","unstructured":"Dressler D, Adib Saberi F (2017a) Safety of botulinum toxin short interval therapy using incobotulinumtoxin A. J Neural Transm 124:437\u2013440","journal-title":"J Neural Transm"},{"key":"2266_CR11","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1007\/978-3-319-46062-8_4","volume-title":"Movement disorders rehabilitation","author":"D Dressler","year":"2017","unstructured":"Dressler D, Adib Saberi F (2017b) Rehabilitation of dystonia. In: Chien HF, Barsottini O (eds) Movement disorders rehabilitation. Springer, New York, pp 67\u201382"},{"key":"2266_CR12","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1159\/000067023","volume":"49","author":"D Dressler","year":"2003","unstructured":"Dressler D, Benecke R (2003) Autonomic side effects of botulinum toxin type B treatment of cervical dystonia and hyperhidrosis. Eur Neurol 49:34\u201338","journal-title":"Eur Neurol"},{"key":"2266_CR13","doi-asserted-by":"publisher","first-page":"132","DOI":"10.1159\/000081463","volume":"52","author":"D Dressler","year":"2004","unstructured":"Dressler D, Bigalke H (2004) Antibody-induced failure of botulinum toxin type B therapy in de novo patients. Eur Neurol 52:132\u2013135","journal-title":"Eur Neurol"},{"key":"2266_CR14","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1007\/s00702-011-0719-1","volume":"119","author":"D Dressler","year":"2012","unstructured":"Dressler D, Mander X, Fink K (2012) Meassuring the potency labelling of onabotulinumtoxinA (Botox\u00ae) and Xeomin\u00ae in an LD50 assay. J Neural Transm 119:13\u201315","journal-title":"J Neural Transm"},{"key":"2266_CR15","doi-asserted-by":"publisher","first-page":"327","DOI":"10.1007\/s00702-014-1252-9","volume":"122","author":"D Dressler","year":"2014","unstructured":"Dressler D, Adib Saberi F, Kollewe K, Schrader C (2014) Safety aspects of incobotulinumtoxinA high dose therapy. J Neural Transm 122:327\u2013333","journal-title":"J Neural Transm"},{"key":"2266_CR16","doi-asserted-by":"publisher","first-page":"251","DOI":"10.1007\/s00702-015-1453-x","volume":"123","author":"D Dressler","year":"2015","unstructured":"Dressler D, Altenmueller E, Bhidayasiri R, Boholega S, Chana P, Chung TM, Frucht S, Garcia-Ruiz PJ, Kaelin A, Kaji R, Kanovsky P, Laskawi R, Micheli F, Orlova O, Relja M, Rosales R, Slawek J, Timerbaeva S, Warner TT, Adib Saberi F (2015) Strategies for treatment of dystonia. J Neural Transm 123:251\u2013258","journal-title":"J Neural Transm"},{"key":"2266_CR17","doi-asserted-by":"publisher","first-page":"253","DOI":"10.1007\/s00702-016-1641-3","volume":"124","author":"D Dressler","year":"2017","unstructured":"Dressler D, Karapantzou C, Rohrbach S, Laskawi R (2017) Frontalis suspension operation to treat patients with blepharospasm and eyelid opening apraxia: long-term results. J Neural Transm 124:253\u2013257","journal-title":"J Neural Transm"},{"key":"2266_CR18","doi-asserted-by":"crossref","unstructured":"Dressler D, Altavista MC, Altenmueller E, Bhidayasiri R, Bohlega S, Chana P, Chung TM; Colosimo C, Fheodoroff K, Garcia-Ruiz PJ, Jeon B, Jin L, Kanovsky P, Milanov I, Micheli F, Orlova O, Pandey S, Pirtosek Z, Relja M, Rosales R, Sag\u00e1stegui-Rodr\u00edguez JA, Shahidi GA, Timerbaeva S, Wan X, Walter U, Adib Saberi F (2020) Consensus guidelines fro botulinum toxin therapy: general algorithms and dosing tables for dystonia and spasticy. J Neural Transm (submitted)","DOI":"10.1007\/s00702-021-02312-4"},{"key":"2266_CR19","doi-asserted-by":"publisher","first-page":"1464","DOI":"10.1001\/archopht.1984.01040031184014","volume":"102","author":"BR Frueh","year":"1984","unstructured":"Frueh BR, Felt DP, Wojno TH, Musch DC (1984) Treatment of blepharospasm with botulinum toxin. A preliminary report. Arch Ophthalmol 102:1464\u20131468","journal-title":"Arch Ophthalmol"},{"key":"2266_CR20","doi-asserted-by":"publisher","first-page":"1623","DOI":"10.1002\/mds.20631","volume":"20","author":"HC Jabusch","year":"2005","unstructured":"Jabusch HC, Zschucke D, Schmidt A, Schuele S, Altenm\u00fcller E (2005) Focal dystonia in musicians: treatment strategies and long-term outcome in 144 patients. Mov Disord 20:1623\u20131626","journal-title":"Mov Disord"},{"key":"2266_CR21","doi-asserted-by":"publisher","first-page":"1161","DOI":"10.1007\/s00702-020-02220-z","volume":"127","author":"A Kutschenko","year":"2020","unstructured":"Kutschenko A, Klietz M, Paracka L, Kollewe K, Schulte-Sutum A, Janssen T, Schrader C, Wegner F, Dressler D (2020) Dysphagia in cervical dystonia patients receiving optimised botulinum toxin therapy. J Neural Transm. 127:1161\u20131165 (epub ahead)","journal-title":"J Neural Transm."},{"key":"2266_CR22","first-page":"259","volume":"14","author":"CD Marsden","year":"1976","unstructured":"Marsden CD (1976) The problem of adult-onset idiopathic torsion dystonia and other isolated dyskinesias in adult life (including blepharospasm, oromandibular dystonia, dystonic writer\u2019s cramp, and torticollis, or axial dystonia). Adv Neurol 14:259\u2013276","journal-title":"Adv Neurol"},{"key":"2266_CR23","doi-asserted-by":"publisher","first-page":"3","DOI":"10.5772\/61878","volume-title":"Botulinum toxin therapy manual for dystonia and spasticity","author":"RL Rosales","year":"2016","unstructured":"Rosales RL, Dressler D (2016) Botulinum toxin type A therapy in dystonia and spasticity\u2014what are current practical applications? In: Rosales RL, Dressler D (eds) Botulinum toxin therapy manual for dystonia and spasticity. Intech Open Acess Publishers, Rijeka, pp 3\u201310"},{"issue":"50","key":"2266_CR24","first-page":"457","volume":"1988","author":"MP Sheehy","year":"1988","unstructured":"Sheehy MP, Rothwell JC, Marsden CD (1988) Writer\u2019s cramp. Adv Neurol 1988(50):457\u2013472","journal-title":"Adv Neurol"},{"key":"2266_CR25","doi-asserted-by":"publisher","first-page":"935","DOI":"10.1007\/s00702-020-02163-5","volume":"127","author":"PRL Siongco","year":"2020","unstructured":"Siongco PRL, Rosales RL, Moore AP, Freynhagen R, Arimura K, Kanovsky P, Kaji R, Fernandez HH, Dressler D (2020) Botulinum neurotoxin injections for muscle-based (dystonia and spasticity) and non-muscle-based (neuropathic pain) pain disorders: a meta-analytic study. J Neural Transm 127:935\u2013951","journal-title":"J Neural Transm"},{"key":"2266_CR26","volume-title":"Manual of botulinum toxin therapy","author":"D Truong","year":"2013","unstructured":"Truong D, Dressler D, Hallett M, Zachary C (2013) Manual of botulinum toxin therapy, 2nd edn. Cambridge University Press, Cambridge","edition":"2"},{"key":"2266_CR27","doi-asserted-by":"publisher","first-page":"923","DOI":"10.1586\/14737175.2014.936387","volume":"14","author":"U Walter","year":"2014","unstructured":"Walter U, Dressler D (2014) Ultrasound guided botulinum toxin injections in neurology. Exp Rev Neurother 14:923\u2013936","journal-title":"Exp Rev Neurother"},{"issue":"Suppl","key":"2266_CR28","doi-asserted-by":"publisher","first-page":"327","DOI":"10.3109\/13682829809179445","volume":"33","author":"R Whurr","year":"1998","unstructured":"Whurr R, Nye C, Lorch M (1998) Meta-analysis of botulinum toxin treatment of spasmodic dysphonia: a review of 22 studies. Int J Lang Commun Disord 33(Suppl):327\u2013329","journal-title":"Int J Lang Commun Disord"},{"key":"2266_CR29","doi-asserted-by":"publisher","first-page":"1321","DOI":"10.1212\/WNL.0000000000003789","volume":"88","author":"J Wissel","year":"2017","unstructured":"Wissel J, Bensmail D, Ferreira J, Molteni F, Satkunam L, Moraleda S, Rekand T, McGuire J, Scheschonka A, Flatau-Baqu\u00e9 B, Simon O, Dressler D, Simpson DM (2017) Safety and efficacy of incobotulinumtoxinA doses up to 800 U in spasticity: the TOWER study. Neurology 88:1321\u20131328","journal-title":"Neurology"},{"key":"2266_CR30","doi-asserted-by":"publisher","first-page":"593","DOI":"10.1002\/ana.10174","volume":"51","author":"KE Zeuner","year":"2002","unstructured":"Zeuner KE, Bara-Jimenez W, Noguchi PS, Goldstein SR, Dambrosia JM, Hallett M (2002) Sensory training for patients with focal hand dystonia. Ann Neurol 51:593\u2013598","journal-title":"Ann Neurol"},{"key":"2266_CR31","first-page":"498","volume":"43","author":"P Zwirner","year":"1995","unstructured":"Zwirner P, Dressler D (1995) Dystonie als Ursache pharyngo-laryngealer Motilit\u00e4tsst\u00f6rungen. HNO 43:498\u2013501","journal-title":"HNO"},{"key":"2266_CR32","doi-asserted-by":"publisher","first-page":"242","DOI":"10.1007\/BF00874096","volume":"254","author":"P Zwirner","year":"1997","unstructured":"Zwirner P, Dressler D, Kruse E (1997) Spasmodic laryngeal dyspnea: a rare manifestation of laryngeal dystonia. Eur Arch Otorhinolaryngol 254:242\u2013245","journal-title":"Eur Arch Otorhinolaryngol"}],"container-title":["Journal of Neural Transmission"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00702-020-02266-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00702-020-02266-z\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00702-020-02266-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,5,6]],"date-time":"2021-05-06T02:04:56Z","timestamp":1620266696000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00702-020-02266-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,10,30]]},"references-count":32,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2021,4]]}},"alternative-id":["2266"],"URL":"https:\/\/doi.org\/10.1007\/s00702-020-02266-z","relation":{},"ISSN":["0300-9564","1435-1463"],"issn-type":[{"value":"0300-9564","type":"print"},{"value":"1435-1463","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,10,30]]},"assertion":[{"value":"18 August 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 October 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 October 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}]}}